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Abstract
Background: Care for women during the third stage aims to reduce the risk of major haemorrhage, but is very variable. 
The current World Health Organisation (WHO) recommendation is that care should include administration of a 
uterotonic (oxytocin, if it is available) soon after birth of the baby, delayed cord clamping, and delivery of the placenta 
by controlled cord traction.
Methods: To ascertain care policies used during the third stage of labour in maternity units in Syria, we conducted a 
survey of 69 maternity units in obstetric and general public hospitals. A brief questionnaire was administered by face to 
face interview or telephone with senior obstetricians and midwives. Outcome measures were the use of prophylactic 
uterotonic drugs, timing of cord clamping, use of controlled cord traction, and treatment for postpartum 
haemorrhage. Obstetricians were asked about both vaginal and caesarean births, midwives only about vaginal births.
Results: Responses were obtained for 66 (96%) hospitals: a midwife and an obstetrician were interviewed in 40; an 
obstetrician only in 20; a midwife only in 6. Responses were similar, although midwives were more likely to report that 
the umbilical cord was clamped after 1-3 minutes or after cessation of pulsation (2/40 obstetricians and 9/40 
midwives). Responses have therefore been combined.
One hospital reported never using a prophylactic uterotonic drug. The uterotonic was Syntometrine® (oxytocin and
ergometrine) in two thirds of hospitals; given after delivery of the placenta in 60 (91%) for vaginal births, and in 47
(78%) for caesarean births. Cord clamping was within 20 seconds at 42 hospitals 64%) for vaginal births and 45 (75%)
for caesarean births. Controlled cord traction was never used in a quarter (17/66) of hospitals for vaginal births and a
half (32/60) for caesarean births.
68% of respondents (45/66) thought there was a need for more randomised trials of interventions during the third
stage of labour.
Conclusion: Most maternity units report using Syntometrine®, usually given after delivery of the placenta, clamping 
the cord within 20 seconds, and using controlled cord traction.
Background
During the third stage of labour, which is from birth of
the baby to delivery of the placenta, women may be at risk
of major haemorrhage, particularly if the uterus does not
retract adequately or the placenta partially separates. A
quarter of the estimated 529,000 maternal deaths which
occur each year, almost all in low and middle income
countries [1], are associated with postpartum haemor-
rhage [2]. Postpartum haemorrhage also contributes to
anaemia and other maternal morbidity following child-
birth [3].
Care for women during the third stage aims to reduce
the risk of major haemorrhage. Expectant, or physiologi-
cal, care is based on awaiting physiological separation and
delivery of the placenta, with intervention only if indi-
cated. Active management is a package of care to acceler-
ate retraction of the uterus, and separation and delivery
of the placenta; thereby minimising blood loss [4]. Tradi-
tionally it includes administration of a prophylactic
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Page 2 of 5uterotonic drug, clamping and cutting of the umbilical
cord, and controlled traction on the cord [5]. Prendiville
et al in their Cochrane Systematic review, due to be
updated, found that active management halves the risk of
postpartum haemorrhage compared with expectant man-
agement [4]. Much of this reduction is due to the prophy-
lactic uterotonic drug: [6,7] oxytocin is the drug of choice,
as it has comparable impact on blood loss with fewer
adverse effects than ergot alkoids [6]. The impact of other
components, such as when is best to give the uterotonic
[8], when to clamp the cord [9] and whether to use con-
trolled cord traction [10], is unclear. Although there is no
clear consensus about the components of active manage-
ment of the third stage of labour [4,11], the current World
Health Organisation (WHO) recommendation is that it
should include administration of a uterotonic (oxytocin, if
it is available) soon after birth of the baby, delayed cord
clamping, and delivery of the placenta by controlled cord
traction [12].
Developing effective strategies to prevent postpartum
haemorrhage requires reliable evidence about the effects
of interventions, and an understanding of current prac-
tice. Information about care during the third stage in low
and middle income countries is scarce, however [13].
Syria is a lower middle income country with a population
of 19.8 million people and annual growth of 2.5% [1,14].
The population is young (median age 21 years compared
to 39 years in the UK) with high fertility (3.3 compared to
1.8 in the UK) [1]. Maternal mortality is 58 deaths per
100,000 live births [15], and 93% of women have a skilled
birth attendant [15]. The caesarean section rate is 15%,
compared to 23% in the UK [11,12]. In Syria the role of
midwives includes providing antenatal and postnatal
care, and conducting normal vaginal births in urban
maternity units. Community midwives provide care for
women in their own homes, as well as attending home
births [11,16]. We surveyed hospitals providing maternity
care in Syria to ask about current polices for care during
the third stage of labour, and assessed how these com-
pared to current evidence.
Methods
All public hospitals run by the Ministry of Health, the
Ministry of Higher Education (University Hospitals), and
the Ministry of Defence (Military Hospitals) in Syria were
identified through the Syrian National Statistics Centre.
Around 30 small maternity units in remote areas and all
private institutions were excluded, as they were difficult
to contact and the number of births at each was small.
The questionnaire was adapted from a self-completed
questionnaire developed for use in the UK [17,18], and
translated into Arabic. It was administered either by face
to face interview or by telephone with a senior obstetri-
cian at each hospital during 2008. Where possible, a
senior midwife was also interviewed. It was explained
that the survey asked about policy within the hospital,
rather than the respondents' personal practice. The ques-
tionnaire was anonymous, and asked about use of pro-
phylactic uterotonic drugs, timing of cord clamping, use
of cord traction, and treatment of postpartum haemor-
rhage. The obstetricians' questionnaire asked about third
stage care for both vaginal and caesarean births, the mid-
wives' questionnaire only about vaginal births.
Data were entered into an excel spreadsheet and double
checked. Analyses were performed using the Statistical
Package for the Social Sciences (SPSS), version 13.0 (SPSS
Inc., Chicago, IL, USA). The study protocol was approved
by the Clinical Research Ethics Committee of the Faculty
of Medicine at Damascus University and the Ministry of
Health in Syria.
Results
Sixty nine public hospitals were identified, of which nine
were military hospitals. At least one response was
obtained for 66 (96%) of hospitals: for 40 hospitals both a
midwife and an obstetrician were interviewed, for 20 hos-
pitals an obstetrician only and for six a midwife only. For
the 40 hospitals where both an obstetrician and midwife
responded, responses were similar between the two
groups, although midwives were more likely to report
that the umbilical cord was clamped after 1-3 minutes or
after cessation of pulsation (2/40 obstetricians and 9/40
midwives). Responses are therefore combined, using the
sixty obstetricians' responses plus the midwife responses
for the six hospitals where only a midwife was inter-
viewed.
One hospital reported never using a prophylactic
uterotonic drug (Table 1). For two thirds of hospitals the
choice of prophylactic uterotonic drug was Syntometrine®
(oxytocin and ergometrine); this was given after delivery
of the placenta in 91% (60/66 hospitals) for vaginal births
and in 78% (47/60) for caesarean births (Table 1). Cord
clamping was within 20 seconds at 42 hospitals 64%) for
vaginal births and 45 (75%) for caesarean births. Draining
the placenta after cord clamping was never used in 74%
(49/66) for vaginal births and 87% (52/60) for Caesarean
births. Controlled cord traction was never used in a quar-
ter (17/66) of the hospitals for vaginal births and more
than half (32/60) for caesarean births.
Two thirds (68%, 45/66) of those interviewed thought
more research evidence from randomised trials of inter-
ventions during third stage was needed. The questions
they thought important were when to give the prophylac-
tic uterotonic (82%, 37/45), when to clamp the cord (29%,
13/45) and whether to use controlled cord traction, or not
(20%, 9/45).
For treatment of postpartum haemorrhage, 80% (53/66)
of hospitals reported always or usually using uterine mas-
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Table 1: Polices for care during the third stage of labour for vaginal and caesarean births†
Vaginal births
n = 66 (%)
Caesarean
births
n = 60 (%)
Use of a prophylactic uterotonic drug
How often is a prophylactic uterotonic used?
always/usually 61 (92) 56 (93)
sometimes 4 (6) 3 (5)
Rarely - - - -
Never 1 (2) 1 (2)
Which uterotonic is usually used?*
Syntometrine‡ 45 (68) 40 (67)
ergometrine 13 (20) 8 (13)
oxytocin 7 (11) 9 (15)
Syntometrine‡ + misoprostol - - 2 (3)
When is the uterotonic drug usually administered?*
with the anterior shoulder - - - -
with delivery of the body 4 (6) 1 (2)
after birth of baby, before cord clamping 1 (2) - -
after birth of baby, after cord clamping - - 11 (18)
after delivery of the placenta 60 (91) 47 (78)
Umbilical cord clamping
When is the cord usually clamped?
within 20 seconds 42 (64) 45 (75)
after 20 seconds - 1 minute 20 (30) 13 (22)
after 1-3 minutes 2 (3) 1 (2)
after >3 minutes 1 (2) - -
after cessation of pulsation 1 (2) 1 (2)
After cutting the cord, is the clamp released to drain the placenta?
always/usually 4 (6) 1 (2)
sometimes 7 (11) 3 (5)
Rarely 6 (9) 4 (7)
Never 49 (74) 52 (87)
Is controlled cord traction used?
always/usually 29 (44) 18 (30)
sometimes 14 (21) 8 (13)
Rarely 6 (9) 2 (3)
never 17 (26) 32 (53)
† Results presented combined for obstetricians and midwives within the practice
‡ oxytocin plus ergometrine
* not applicable for one hospital where a prophylactic uterotonic is never used
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bladder; a quarter (23%, 15/66) always or usually use
bimanual compression of the uterus, and two thirds (61%,
40/66) use Syntometrine® as the drug of first choice (Table
2).
Discussion
Our survey of maternity unit policy for care during the
third stage of labour in Syria found poor compliance with
WHO recommendations [19]. Although use of a prophy-
lactic uterotonic drug was almost universal, and has
improved since 2000 when only 13% of Syrian hospitals
reported using a uterotonic for normal births [16], the
choice of drug was usually Syntometrine®. The uterotonic
drug was usually given after delivery of the placenta.
Optimal timing for administration of the uterotonic is
unclear. The WHO recommendation that this be 'soon
after birth of the baby' [19] implies before delivery of the
placenta; and to be considered active management of the
third stage it should be given during the third stage. The
uterotonic drug is given after delivery of the placenta in
some European countries [20], and in the USA [21].
Timing of cord clamping is controversial. Although
WHO recommends delayed clamping, how long to delay
is not specified [19]. The Cochrane Review shows prom-
ising benefits associated with delayed, or deferred, clamp-
ing rather than early clamping, but further evidence is
needed to provide evidence about long term outcome and
reassurance about safety [9]. The relatively low use of
controlled cord traction is similar to many countries in
Europe [20], although not to the UK where this practice is
widespread [18,20].
Our study only included public hospitals. However, it is
in public hospitals where most people in Syria receive
their care, and it is in these that most of the morbidity
and mortality occurs. Also, we did not observe actual
practice which may have differed from reported policy.
Midwives' and obstetricians' responses were similar
within each unit; however, suggesting policy may have
been agreed within the hospital.
We did not explore reasons why reported policies for
active management of the third stage did not comply with
current international recommendations. However, an
earlier study in Egypt found that factors were lack of writ-
ten protocols, particularly for normal births, poor under-
standing of active and physiological management, and
fear that early use of a prophylactic uterotonic might trap
the placenta in the uterus [22]. This belief that early
uterotonic use will lead to retained placenta is also
reported in the USA [21]. For women with low risk of
haemorrhage, active management is associated with an
increase in the need for manual removal of the placenta,
compared with physiological management [4]. Further
research is needed to assess whether this risk is influ-
enced by timing of administration of the uterotonic, or by
reducing the placental circulation, either by deferred cord
clamping or placental drainage.
Variations in strategies used for treatment of women
with postpartum haemorrhage were also reported. Simi-
lar variation has been reported elsewhere, and there is a
need for better evidence to support guidelines for treat-
ment of women with postpartum haemorrhage [20,23].
Advanced life support in obstetrics [24] in addition to the
traditional methods such as massaging the uterus, blad-
der catheterisation, bimanual compression and the use of
a uterotonic drug have been implemented in Syria,
although there are no national guidelines [16]. Our find-
ings suggest a national policy for postpartum haemor-
rhage would help provide more coherent care in Syria.
Conclusions
Most maternity units report using Syntometrine®, usually
given after delivery of the placenta, clamping the cord
Table 2: Immediate treatment for postpartum haemorrhage
n = 66 (%)















What is the drug of first choice for treatment 
of postpartum haemorrhage?
Syntometrine† 40 (61)
ergometrine alone 10 (15)
oxytocin alone 8 (12)
Syntometrine† + misoprostol 6 (9)
misoprostol alone 2 (3)
† oxytocin and ergometrine
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Although active management of the third stage of labour
is widely recommended to reduce the risk of postpartum
haemorrhage, there remains uncertainty about the effects
of some of the components. Nevertheless, this survey
suggests that there is scope for improving compliance
with evidence-based practice for care during the third
stage of labour in Syria.
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